U.S. FDA grants ‘breakthrough’ status to psilocybin mushroom therapy for untreatable depression
The US Food and Drug Administration has just granted a “Breakthrough Therapy” designation to a treatment that uses psychedelic mushrooms as a therapy for treatment-resistant depression.









